J. Kevin Massey is the CEO of the Arlington Consulting Group, which provides healthcare technology innovation, quality improvement, strategy, and program development/support. Massey has been a member of the advisory board for the National RX Drug Abuse & Heroin Summit since 2013 and has co-published articles and presented at numerous conferences as an expert. For over 25 years, Massey has served in management, executive, and consulting capacities in the fields of public health, healthcare, and financial services. Prior to Arlington Consulting Group, he served as the Health Services & Court Compliance Administrator for Wellpath, a leading national contracted provider of correctional healthcare services in the US. He led an integrated clinical team of more than 100 professionals who served over 1,300 patients located onsite at the New Orleans Parish Jail. Previously, as the Director of Strategic Business Development at Community Health Center, Inc., he co-led the development of clinical innovations that improved specialty healthcare access among underserved primary care patients across the US. Prior leadership roles include: Director of Violence and Injury Prevention at the Delaware Department of Health, where he led health policy, clinical practice, and executed broad-based prevention/population health programs, including analyzing the PDMP; Chief Operating Officer at the Kent Community Health Center, a $20M outpatient primary care health center; and Interim Director of Marketing/Community Engagement for United Healthcare, Delaware Community Medicaid Plan.